CLINICAL_TRIALS trial_result · 2022-08-03

Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]

Phase 2 trial update for LY3016859 in diabetic peripheral neuropathic pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED | Results posted: 2022-08-03